Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New preterm labor is drug safe with favorable pharmacokinetic profile

Aug. 31, 2018

Duzallo, a fixed-dose combination therapy for gout, approved in Europe

Aug. 30, 2018

Potential new anti-obesity target identified

Aug. 29, 2018

Early diagnosis of gestational diabetes

Aug. 29, 2018

Poxel completes enrollment in Japanese TIMES 3 trial of imeglimin in type 2 diabetes

Aug. 28, 2018

FDA issues complete response letter for Waylivra NDA

Aug. 28, 2018

European Commission approves Mepsevii for non-neurological manifestations of MPS VII

Aug. 28, 2018

Merck & Co. reports development of a full allosteric agonist of GPR40

Aug. 28, 2018

Keeping leptin active

Aug. 28, 2018

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

Aug. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...